FDA Approves Airsupra Asthma Rescue Inhaler
AstraZeneca's Airsupra is the first FDA-approved combination of an inhaled corticosteroid and a short-acting beta-agonist for prevention of asthma exacerbations.
Tag: AirSupra
All
Latest
AstraZeneca's Airsupra is the first FDA-approved combination of an inhaled corticosteroid and a short-acting beta-agonist for prevention of asthma exacerbations.